Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Christoph

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Pharmaceutical Research|November 17, 2007
Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antinociceptive response in the presence of competitive antagonism: the interaction between tramadol and its active metabolite on micro-opioid agonism and monoamine reuptake inhibition, in the ratHorst Beier, María J Garrido, Thomas Christoph, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2013
Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in miceThomas Christoph, Wolfgang Schröder, Ronald J Tallarida, et al.
Geburtshilfe Und Frauenheilkunde|April 7, 2025
Malignant Peripheral Nerve Sheath Tumor (MPNST) of the Uterine Cervix - A Systematic Literature Review and New Case Report with Possible New Therapeutic ApproachesWei He, Zhi Min Hu, Zhi Hui Yang, et al.
Behavioural Brain Research|May 9, 2018
Standard analgesics reverse burrowing deficits in a rat CCI model of neuropathic pain, but not in models of type 1 and type 2 diabetes-induced neuropathic painKris Rutten, Stacey A Gould, Luke Bryden, et al.
European Journal of Pharmacology|January 22, 2005
Broad analgesic profile of buprenorphine in rodent models of acute and chronic painThomas Christoph, Babette Kögel, Klaus Schiene, et al.
European Journal of Pharmacology|June 7, 2011
Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic painThomas Christoph, Jean De Vry, Klaus Schiene, et al.
Scientific Reports|July 30, 2022
LITOS: a versatile LED illumination tool for optogenetic stimulationThomas Christoph Höhener, Alex Erich Landolt, Coralie Dessauges, et al.
European Journal of Pharmacology|May 13, 2018
Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic painKlaus Schiene, Wolfgang Schröder, Klaus Linz, et al.
Veterinary Journal (London, England : 1997)|December 4, 2014
Terrestrial rabies control in the European Union: historical achievements and challenges aheadThomas Müller, Conrad Martin Freuling, Patrick Wysocki, et al.
Behavioural Pharmacology|August 31, 2018
Inhibition of experimental visceral pain in rodents by cebranopadolKlaus Schiene, Wolfgang Schröder, Klaus Linz, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Pharmaceutical Research|November 17, 2007
Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antinociceptive response in the presence of competitive antagonism: the interaction between tramadol and its active metabolite on micro-opioid agonism and monoamine reuptake inhibition, in the ratHorst Beier, María J Garrido, Thomas Christoph, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2013
Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in miceThomas Christoph, Wolfgang Schröder, Ronald J Tallarida, et al.
Geburtshilfe Und Frauenheilkunde|April 7, 2025
Malignant Peripheral Nerve Sheath Tumor (MPNST) of the Uterine Cervix - A Systematic Literature Review and New Case Report with Possible New Therapeutic ApproachesWei He, Zhi Min Hu, Zhi Hui Yang, et al.
Behavioural Brain Research|May 9, 2018
Standard analgesics reverse burrowing deficits in a rat CCI model of neuropathic pain, but not in models of type 1 and type 2 diabetes-induced neuropathic painKris Rutten, Stacey A Gould, Luke Bryden, et al.
European Journal of Pharmacology|January 22, 2005
Broad analgesic profile of buprenorphine in rodent models of acute and chronic painThomas Christoph, Babette Kögel, Klaus Schiene, et al.
European Journal of Pharmacology|June 7, 2011
Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic painThomas Christoph, Jean De Vry, Klaus Schiene, et al.
Scientific Reports|July 30, 2022
LITOS: a versatile LED illumination tool for optogenetic stimulationThomas Christoph Höhener, Alex Erich Landolt, Coralie Dessauges, et al.
European Journal of Pharmacology|May 13, 2018
Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic painKlaus Schiene, Wolfgang Schröder, Klaus Linz, et al.
Veterinary Journal (London, England : 1997)|December 4, 2014
Terrestrial rabies control in the European Union: historical achievements and challenges aheadThomas Müller, Conrad Martin Freuling, Patrick Wysocki, et al.
Behavioural Pharmacology|August 31, 2018
Inhibition of experimental visceral pain in rodents by cebranopadolKlaus Schiene, Wolfgang Schröder, Klaus Linz, et al.
Pageof 8